The blocking of TGFβ partially rescued the expression of these NK-cell-activating receptors [59], suggesting that soluble molecules in the tumor microenvironment could be responsible for the modulation of the NK cell receptor repertoire (Figure 1). The gene discussed is NCR1; the disease is neoplasm.